Cargando…
The evolving role of radiation in pancreatic cancer
Pancreatic cancer is the fourth leading cause of cancer mortality in the United States. Chemotherapy in resectable pancreatic cancer has improved survival by 10-20%. It only converted 10-30% of the borderline resectable and locally advanced pancreatic cancers to be surgically resectable. Radiation t...
Autores principales: | Malla, Midhun, Fekrmandi, Fatemeh, Malik, Nadia, Hatoum, Hassan, George, Sagila, Goldberg, Richard M., Mukherjee, Sarbajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875560/ https://www.ncbi.nlm.nih.gov/pubmed/36713520 http://dx.doi.org/10.3389/fonc.2022.1060885 |
Ejemplares similares
-
Serotonin Pathway in Cancer
por: Balakrishna, Pragathi, et al.
Publicado: (2021) -
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus
por: Malla, Midhun, et al.
Publicado: (2022) -
The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
por: Gkika, Eleni, et al.
Publicado: (2020) -
Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
por: Malla, Midhun, et al.
Publicado: (2022) -
Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift
por: Chawla, Akhil, et al.
Publicado: (2019)